Initiatiefnota van de leden Ploumen, Van Gerven en Ellemeet: “Big Farma: niet gezond!”

This motion concerns the influence and business practices of large pharmaceutical companies, referred to as 'Big Pharma'. It seeks to address concerns regarding health policy, pricing, and the transparency of the pharmaceutical industry to ensure a more sustainable and fair healthcare system. This procedure primarily affects pharmaceutical companies and health policymakers. It aims to change how the state interacts with the industry to prioritize public health over corporate profit.